# Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds

> **NCT01205061** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 162 (actual)

## Conditions studied

- Skin Wrinkling

## Interventions

- **DEVICE:** Emervel Deep Lidocaine
- **DEVICE:** Juvederm Ultra Plus

## Key facts

- **NCT ID:** NCT01205061
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09-27
- **Primary completion:** 2011-06-20
- **Final completion:** 2012-01-12
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205061, "Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01205061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*